{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:45:47Z","timestamp":1790642747923,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.joca.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T20:50:35Z","timestamp":1473454235000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["I\u03baB kinase inhibition as a potential treatment of\u00a0osteoarthritis \u2013\u00a0results of a clinical proof-of-concept study"],"prefix":"10.1016","volume":"25","author":[{"given":"K.","family":"Grothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Flechsenhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Paehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ritzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Saas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rudolphi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.joca.2016.08.010_bib1","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","article-title":"The NFkB signalling pathway in osteoarthritis","volume":"vol. 45","author":"Rigoglou","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.joca.2016.08.010_bib2","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1096\/fj.08-109355","article-title":"The IKK-NF-kB pathway: a source for novel molecular drug targets in pain therapy?","volume":"22","author":"Niederberger","year":"2008","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.joca.2016.08.010_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","article-title":"NF\u03baB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis","volume":"14","author":"Roman-Blas","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2016.08.010_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/138945010791011938","article-title":"OA, NF-kB signaling: multiple angles to target OA","volume":"11","author":"Marcu","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.joca.2016.08.010_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.joca.2016.08.010_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tips.2007.01.005","article-title":"Ikappa B kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges","volume":"28","author":"Strnad","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.joca.2016.08.010_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0945-053X(02)00007-0","article-title":"Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes","volume":"21","author":"Liacini","year":"2002","journal-title":"Matrix Biol"},{"key":"10.1016\/j.joca.2016.08.010_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kB system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev Drug Dev"},{"issue":"2","key":"10.1016\/j.joca.2016.08.010_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.joca.2016.08.010_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1523\/JNEUROSCI.3118-03.2004","article-title":"Specific inhibition of Ikappa B kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats","volume":"24","author":"Tegeder","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.joca.2016.08.010_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01110-2","article-title":"Adenosine A\u00b3 receptor activation produces nociceptive behaviour and 3","volume":"333","author":"Sawynok","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joca.2016.08.010_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/sj.bjp.0702192","article-title":"Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw","volume":"125","author":"Bileviciute","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joca.2016.08.010_bib13","article-title":"Osteoarthritis, comorbidity and pain: their role in determining functional limitations in older populations (European project on Osteoarthritis)","volume":"9","author":"Zambon","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.joca.2016.08.010_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.joca.2012.03.001","article-title":"Responsiveness of the OARSI OMERACT osteoarthritis pain and function measures","volume":"20","author":"Bond","year":"2012","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458416302461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458416302461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:42:17Z","timestamp":1761018137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458416302461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1063458416302461"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2016.08.010","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"I\u03baB kinase inhibition as a potential treatment of\u00a0osteoarthritis \u2013\u00a0results of a clinical proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}